What is Altimmune Inc Quarterly Revenue?

Altimmune Inc Quarterly Revenue Altimmune Inc Dec-2024 Quarterly Revenue is $0 Million which is growth of -86.5% YoY.

What is Altimmune Inc Quarterly Net Profit?

Altimmune Inc Quarterly Net Profit Altimmune Inc Dec-2024 Quarterly Net Profit is $-23 Million which is growth of 26.7% YoY.

Altimmune Inc Annual Revenue Altimmune Inc Dec-2024 Annual Revenue is $0 Million which is growth of -95.3% YoY.

Altimmune Inc Annual Net Profit Altimmune Inc Dec-2024 Annual Net Profit is $-95 Million which is growth of -7.5% YoY.

Altimmune Inc Total Shareholders Fund Altimmune Inc Dec-2024 Total Shareholders Fund is $124 Million which is growth of -36.4% YoY.

Altimmune Inc Total Assets Altimmune Inc Dec-2024 Total Assets is $139 Million which is growth of -33.9% YoY.

Altimmune Inc Book Value Per Share Altimmune Inc Book Value Per Share is $2 which is growth of -24.6% YoY.

Altimmune Inc ROE Altimmune Inc ROE is -60% which is growth of 13.2% YoY.

Altimmune Inc Cash From Operating Activity Altimmune Inc Dec-2024 Cash From Operating Activity is $-80 Million which is growth of -5.3% YoY.

Altimmune Inc Net Cash Flow Altimmune Inc Dec-2024 Net Cash Flow is $-98 Million which is growth of -508.7% YoY.

XNAS: ALT

4.97 0.12 (2.47%)

1.7M XNAS Volume

XNAS 23 Apr, 2025 5:30 PM (EDT)